XML 56 R37.htm IDEA: XBRL DOCUMENT v3.8.0.1
Business segment information (Tables)
12 Months Ended
Dec. 31, 2017
Segment Reporting [Abstract]  
Schedule of Net Sales by Reporting Segment

The table below presents net sales by reporting segment:

 

 

 

Year Ended December 31,

 

 

 

2017

 

 

2016

 

 

2015

 

(U.S. Dollars, in thousands)

 

Net Sales

 

 

Percent of

Total Net

Sales

 

 

Net Sales

 

 

Percent of

Total Net

Sales

 

 

Net Sales

 

 

Percent of

Total Net

Sales

 

BioStim

 

$

185,900

 

 

 

42.9

%

 

$

176,561

 

 

 

43.1

%

 

$

164,955

 

 

 

41.6

%

Extremity Fixation

 

 

103,242

 

 

 

23.8

%

 

 

102,683

 

 

 

25.1

%

 

 

96,034

 

 

 

24.2

%

Spine Fixation

 

 

81,957

 

 

 

18.9

%

 

 

72,632

 

 

 

17.7

%

 

 

75,668

 

 

 

19.1

%

Biologics

 

 

62,724

 

 

 

14.4

%

 

 

57,912

 

 

 

14.1

%

 

 

59,832

 

 

 

15.1

%

Net sales

 

$

433,823

 

 

 

100.0

%

 

$

409,788

 

 

 

100.0

%

 

$

396,489

 

 

 

100.0

%

 

Summary of Non-GAAP Net Margin by Reporting Segment

The following table presents Non-GAAP net margin, and internal metric that the Company defines as gross profit less sales and marketing expense, by reporting segment:

 

 

 

Year Ended December 31,

 

(U.S. Dollars, in thousands)

 

2017

 

 

2016

 

 

2015

 

BioStim

 

$

77,369

 

 

$

75,469

 

 

$

67,878

 

Extremity Fixation

 

 

31,071

 

 

 

30,526

 

 

 

29,493

 

Spine Fixation

 

 

8,730

 

 

 

8,650

 

 

 

8,547

 

Biologics

 

 

25,692

 

 

 

26,891

 

 

 

27,226

 

Corporate

 

 

(446

)

 

 

(888

)

 

 

(1,260

)

Non-GAAP net margin

 

$

142,416

 

 

$

140,648

 

 

$

131,884

 

General and administrative

 

 

74,388

 

 

 

74,404

 

 

 

87,157

 

Research and development

 

 

29,700

 

 

 

28,803

 

 

 

26,389

 

SEC / FCPA matters and related costs

 

 

(2,483

)

 

 

2,005

 

 

 

9,083

 

Charges related to U.S. Government resolutions

 

 

 

 

 

14,369

 

 

 

 

Operating income

 

$

40,811

 

 

$

21,067

 

 

$

9,255

 

Interest income (expense), net

 

 

(416

)

 

 

763

 

 

 

(489

)

Other expense, net

 

 

(4,004

)

 

 

(2,806

)

 

 

(259

)

Income before income taxes

 

$

36,391

 

 

$

19,024

 

 

$

8,507

 

 

Schedule of Depreciation and Amortization by Reporting Segment

The following table presents depreciation and amortization by reporting segment:

 

 

 

Year Ended December 31,

 

(U.S. Dollars, in thousands)

 

2017

 

 

2016

 

 

2015

 

BioStim

 

$

2,133

 

 

$

2,754

 

 

$

2,933

 

Extremity Fixation

 

 

6,040

 

 

 

5,742

 

 

 

6,636

 

Spine Fixation

 

 

6,949

 

 

 

8,118

 

 

 

10,050

 

Biologics

 

 

752

 

 

 

1,011

 

 

 

1,157

 

Corporate

 

 

4,250

 

 

 

3,216

 

 

 

147

 

Total

 

$

20,124

 

 

$

20,841

 

 

$

20,923

 

 

Summary of Net Sales by Geographic Destination

The following data includes net sales by geographic destination:

 

(U.S. Dollars, in thousands)

 

2017

 

 

2016

 

 

2015

 

U.S.

 

$

345,145

 

 

$

316,873

 

 

$

305,505

 

Italy

 

 

17,059

 

 

 

16,664

 

 

 

15,655

 

United Kingdom

 

 

8,725

 

 

 

10,362

 

 

 

11,376

 

Brazil

 

 

10,356

 

 

 

11,334

 

 

 

13,512

 

Others

 

 

52,538

 

 

 

54,555

 

 

 

50,441

 

Net sales

 

$

433,823

 

 

$

409,788

 

 

$

396,489

 

 

Summary of Property, Plant and Equipment of Reporting Segments by Geographic Area

The following data includes property, plant and equipment by geographic area:

 

(U.S. Dollars, in thousands)

 

2017

 

 

2016

 

U.S.

 

$

34,008

 

 

$

38,398

 

Italy

 

 

7,658

 

 

 

7,013

 

United Kingdom

 

 

382

 

 

 

617

 

Brazil

 

 

475

 

 

 

769

 

Others

 

 

2,616

 

 

 

2,119

 

Total

 

$

45,139

 

 

$

48,916